FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ulrich Feige

Research Profile

Disorders

Living Beings

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Georg Schett; Marina Stolina; Denise Dwyer; Debra Zack; Stefan Uderhardt; Gerhard Krönke; Paul Kostenuik; Ulrich Feige
Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.
Georg Schett; Marina Stolina; Brad Bolon; Scot Middleton; Matthew Adlam; Heather Brown; Li Zhu; Ulrich Feige; Debra Zack
Analysis of the kinetics of osteoclastogenesis in arthritic rats.
Marina Stolina; Stephen Adamu; Michael Ominsky; Denise Dwyer; Frank Asuncion; Zhaopo Geng; Scot Middleton; Heather Brown; Jim Pretorius; Georg Schett; Brad Bolon; Ulrich Feige; Debra Zack; Paul J Kostenuik
RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ulrich Feige (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Georg Schett; Marina Stolina; Denise Dwyer; Debra Zack; Stefan Uderhardt; Gerhard Krönke; Paul Kostenuik; Ulrich Feige
Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.
Arthritis and rheumatism 2009;60(9):2644-54.
2005: Georg Schett; Marina Stolina; Brad Bolon; Scot Middleton; Matthew Adlam; Heather Brown; Li Zhu; Ulrich Feige; Debra Zack
Analysis of the kinetics of osteoclastogenesis in arthritic rats.
Arthritis and rheumatism 2005;52(10):3192-201.
2005: Marina Stolina; Stephen Adamu; Michael Ominsky; Denise Dwyer; Frank Asuncion; Zhaopo Geng; Scot Middleton; Heather Brown; Jim Pretorius; Georg Schett; Brad Bolon; Ulrich Feige; Debra Zack; Paul J Kostenuik
RANKL is a marker and mediator of local and systemic bone loss in two rat models of inflammatory arthritis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2005;20(10):1756-65.
2005: Elizabeth C Wahl; Daniel S Perrien; James Aronson; Zhendong Liu; Terry W Fletcher; Robert A Skinner; Ulrich Feige; Larry J Suva; Thomas M Badger; Charles K Lumpkin
Ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis: a role for the tumor necrosis factor signaling axis.
Alcoholism, clinical and experimental research 2005;29(8):1466-72.
2005: Georg Schett; Scot Middleton; Brad Bolon; Marina Stolina; Heather Brown; Li Zhu; Jim Pretorius; Debra Zack; Paul J Kostenuik; Ulrich Feige
Additive bone-protective effects of anabolic treatment when used in conjunction with RANKL and tumor necrosis factor inhibition in two rat arthritis models.
Arthritis and rheumatism 2005;52(5):1604-11.
2005: Masahiko Kobayashi; Ginette R Squires; Aisha Mousa; Michael Tanzer; David J Zukor; John Antoniou; Ulrich Feige; A Robin Poole
Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Arthritis and rheumatism 2005;52(1):128-35.
2004: Daniel S Perrien; Elizabeth C Wahl; William R Hogue; Ulrich Feige; James Aronson; Martin J J Ronis; Thomas M Badger; Charles K Lumpkin
IL-1 and TNF antagonists prevent inhibition of fracture healing by ethanol in rats.
Toxicological sciences : an official journal of the Society of Toxicology 2004;82(2):656-60.
2004: Brad Bolon; Giuseppe Campagnuolo; L Zhu; Diane Duryea; Debra Zack; Ulrich Feige
Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee.
Veterinary pathology 2004;41(3):235-43.
2004: Jochen Zwerina; Silvia Hayer; Makiyeh Tohidast-Akrad; Helga Bergmeister; Kurt Redlich; Ulrich Feige; Colin Dunstan; george kollias; Günter Steiner; Josef Smolen; Georg Schett
Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
Arthritis and rheumatism 2004;50(1):277-90.
2004: Brad Bolon; Sean Morony; Y Cheng; Yi-Ling Hu; Ulrich Feige
Osteoclast numbers in Lewis rats with adjuvant-induced arthritis: identification of preferred sites and parameters for rapid quantitative analysis.
Veterinary pathology 2004;41(1):30-6.
2003: Carl K Edwards; Steven W Martin; James Seely; Olaf Kinstler; Scott Buckel; Alison M Bendele; Mary Ellen Cosenza; Ulrich Feige; Tadahiko Kohno
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases.
Advanced drug delivery reviews 2003;55(10):1315-36.
2003: Conny Gysemans; Katinka Stoffels; Annapaula Giulietti; Lut Overbergh; Mark Waer; M Lannoo; Ulrich Feige; Chantal Mathieu
Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.
Diabetologia 2003;46(8):1115-23.
2002: Brad Bolon; Victoria Shalhoub; Paul J Kostenuik; Giuseppe Campagnuolo; Sean Morony; william boyle; Debra Zack; Ulrich Feige
Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis.
Arthritis and rheumatism 2002;46(12):3121-35.
2002: Daniel S Perrien; Elizabeth C Brown; Terry W Fletcher; David J Irby; James Aronson; Guan G Gao; Robert A Skinner; William R Hogue; Ulrich Feige; Larry J Suva; Martin J J Ronis; Thomas M Badger; Charles K Lumpkin
Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis.
The Journal of pharmacology and experimental therapeutics 2002;303(3):904-8.
2002: Angela Coxon; Brad Bolon; Juan Estrada; Stephen Kaufman; Sheila Scully; Alana Rattan; Diane Duryea; Yi-Ling Hu; Karen Rex; Efrain Pacheco; Gwyneth Van; Debra Zack; Ulrich Feige
Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis.
Arthritis and rheumatism 2002;46(10):2604-12.
2002: Brad Bolon; Giuseppe Campagnuolo; Ulrich Feige
Duration of bone protection by a single osteoprotegerin injection in rats with adjuvant-induced arthritis.
Cellular and molecular life sciences : CMLS 2002;59(9):1569-76.
2002: Giuseppe Campagnuolo; Brad Bolon; Ulrich Feige
Kinetics of bone protection by recombinant osteoprotegerin therapy in Lewis rats with adjuvant arthritis.
Arthritis and rheumatism 2002;46(7):1926-36.
2001: Ulrich Feige
Osteoprotegerin.
Annals of the rheumatic diseases 2001;60 Suppl 3():iii81-4.
2001: Jason J Rosenberg; S W Martin; J E Seely; Olaf Kinstler; Gregory C Gaines; K Fukuzuka; J Rose; T Kohno; william boyle; A Nelson; GL Kieft; W S Marshall; Ulrich Feige; J Gasser; J St Clair; J Frazier; Amer Abouhamze; Lyle L Moldawer; Carl K Edwards
Development of a novel, nonimmunogenic, soluble human TNF receptor type I (sTNFR-I) construct in the baboon.
Journal of applied physiology (Bethesda, Md. : 1985) 2001;91(5):2213-23.
2001: Jean-Michel Dayer; Ulrich Feige; Carl K Edwards; D Burger
Anti-interleukin-1 therapy in rheumatic diseases.
Current opinion in rheumatology 2001;13(3):170-6.
2000: M W Davis; Ulrich Feige; Alison M Bendele; Steven W Martin; Carl K Edwards
Treatment of rheumatoid arthritis with PEGylated recombinant human soluble tumour necrosis factor receptor type I: a clinical update.
Annals of the rheumatic diseases 2000;59 Suppl 1():i41-3.
2000: Ulrich Feige; Yi-Ling Hu; J Gasser; Giuseppe Campagnuolo; L Munyakazi; Brad Bolon
Anti-interleukin-1 and anti-tumor necrosis factor-alpha synergistically inhibit adjuvant arthritis in Lewis rats.
Cellular and molecular life sciences : CMLS 2000;57(10):1457-70.
1999: Young-Yun Kong; Ulrich Feige; Ildiko Sarosi; Brad Bolon; A Tafuri; Sean Morony; Charles Capparelli; J Li; R Elliott; Susan McCabe; T Wong; Giuseppe Campagnuolo; E Moran; Earl R Bogoch; Gwyneth Van; L T Nguyen; Pamela S Ohashi; David L Lacey; E Fish; william boyle; Josef M Penninger
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Nature 1999;402(6759):304-9.
1999: M Xia; J Gasser; Ulrich Feige
Dexamethasone enhances CTLA-4 expression during T cell activation.
Cellular and molecular life sciences : CMLS 1999;55(12):1649-56.
1996: Ulrich Feige; W van Eden
Infection, autoimmunity and autoimmune disease.
EXS 1996;77():359-73.
1994: Ulrich Feige; B S Polla
Hsp70--a multi-gene, multi-structure, multi-function family with potential clinical applications.
Experientia 1994;50(11-12):979-86.
1994: T J Hall; J Gasser; Ulrich Feige; P G Ferrini
Effects of the cytokine synthesis inhibitor CGP 47969A on nitric oxide production by lipopolysaccharide-stimulated J774A.1 macrophages.
Agents and actions 1994;43(1-2):60-3.
1994: Markus G Grütter; J van Oostrum; JP Priestle; E Edelmann; U Joss; Ulrich Feige; Klaus Dieter Vosbeck; A Schmitz
A mutational analysis of receptor binding sites of interleukin-1 beta: differences in binding of human interleukin-1 beta muteins to human and mouse receptors.
Protein engineering 1994;7(5):663-71.
1994: C Tischmann; Ulrich Feige; D Rüegg; J Gasser; Gerd Pluschke
Sequence and diversity of rat T-cell receptor alpha-chain-encoding genes.
Immunogenetics 1994;39(2):155-8.
1994: Ulrich Feige; A Schulmeister; Juergen Mollenhauer; Kay Brune; H Bang
A constitutive 65 kDa chondrocyte protein as a target antigen in adjuvant arthritis in Lewis rats.
Autoimmunity 1994;17(3):233-9.
1993: H Bang; Kay Brune; C Nager; Ulrich Feige
Interleukin-8 is a cyclosporin A binding protein.
Experientia 1993;49(6-7):533-8.
1992: X D Yang; Ulrich Feige
Heat shock proteins in autoimmune disease. From causative antigen to specific therapy?
Experientia 1992;48(7):650-6.
1992: Ulrich Feige; Juergen Mollenhauer
Heat shock proteins. Introduction.
Experientia 1992;48(7):621-2.
1992: Michael John Parnham; Ulrich Feige
Structural and functional properties of heat-shock proteins in inflammation and immunity. European workshop on inflammation. Airport meeting, March 15, 1991. Frankfurt airport, Germany.
Agents and actions 1992;35(1-2):34-6.
1992: X D Yang; J Gasser; Ulrich Feige
Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat shock protein: specificity and mechanism.
Clinical and experimental immunology 1992;87(1):99-104.
1991: Ulrich Feige; I R Cohen
The 65-kDa heat-shock protein in the pathogenesis, prevention and therapy of autoimmune arthritis and diabetes mellitus in rats and mice.
Springer seminars in immunopathology 1991;13(1):99-113.
1991: X D Yang; Ulrich Feige
The 65kD heat shock protein: a key molecule mediating the development of autoimmune arthritis?
Autoimmunity 1991;9(1):83-8.
1990: X D Yang; J Gasser; Ulrich Feige
Prevention of adjuvant arthritis in rats by a nonapeptide from the 65-kD mycobacterial heat-shock protein.
Clinical and experimental immunology 1990;81(2):189-94.
1990: X D Yang; J Gasser; B Riniker; Ulrich Feige
Treatment of adjuvant arthritis in rats: vaccination potential of a synthetic nonapeptide from the 65 kDa heat shock protein of mycobacteria.
Journal of autoimmunity 1990;3(1):11-23.
1989: Ulrich Feige; A Karbowski; C Rordorf-Adam; A Pataki
Arthritis induced by continuous infusion of hr-interleukin-1 alpha into the rabbit knee-joint.
International journal of tissue reactions 1989;11(5):225-38.
1989: T Häupl; Gerd R Burmester; G Hahn; Ulrich Feige; C Rordorf-Adam; Joachim R Kalden
Differential immunological response of patients with rheumatoid arthritis towards two different Epstein-Barr virus strains: inhibition of interleukin-1 release by the B95-8, but not the P3HR-1 virus strain.
Rheumatology international 1989;9(3-5):153-60.
1989: C Rordorf-Adam; Janis Lazdins; K Woods-Cook; E Alteri; R Henn; T Geiger; Ulrich Feige; H Towbin; F Erard
An assay for the detection of interleukin-1 synthesis inhibitors: effects of antirheumatic drugs.
Drugs under experimental and clinical research 1989;15(8):355-62.
1988: A Schweizer; Ulrich Feige; A Fontana; K Müller; C A Dinarello
Interleukin-1 enhances pain reflexes. Mediation through increased prostaglandin E2 levels.
Agents and actions 1988;25(3-4):246-51.
1987: C Rordorf; A Pataki; V Nogues; F Schlager; Ulrich Feige; M Glatt
Arthritis in MRL/LPR mice and in collagen II sensitized DBA-1 mice and their use in pharmacology.
International journal of tissue reactions 1987;9(4):341-7.
1986: L M Farmer; G Watt; M Glatt; A Blaettler; N Loutis; Ulrich Feige
Delayed type hypersensitivity (DTH) to type II collagen (CII) in DBA-1 mice.
Clinical and experimental immunology 1986;65(2):329-35.
1985: G Zwadlo; E B Bröcker; D B von Bassewitz; Ulrich Feige; Clemens Sorg
A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes.
Journal of immunology (Baltimore, Md. : 1950) 1985;134(3):1487-92.
1985: Clemens Sorg; E B Bröcker; G Zwadlo; K Redmann; Ulrich Feige; W Ax; A C Feller
A monoclonal antibody to a formaldehyde-resistant epitope on the nonpolymorphic constant part of the HLA-DR antigens.
Transplantation 1985;39(1):90-3.
1984: Ulrich Feige; C Sorg
Collection of large quantities of mononuclear cells from individual donors by continuous flow centrifugation leukapheresis.
Journal of immunological methods 1984;66(1):161-70.
1984: M F Prescott; K R Müller; R Flammer; Ulrich Feige
The effect of LDL and modified LDL on macrophage secretion products.
Agents and actions. Supplements 1984;16():163-70.
1983: M Imort; M Zühlsdorf; Ulrich Feige; A Hasilik; K von Figura
Biosynthesis and transport of lysosomal enzymes in human monocytes and macrophages. Effects of ammonium chloride, zymosan and tunicamycin.
The Biochemical journal 1983;214(3):671-8.
1983: C Ramb; U Malorny; Ulrich Feige; C Sorg
Characterization of human lymphocyte derived chemotactic factors for mononuclear phagocytes--I. Production and detection.
Molecular immunology 1983;20(3):317-24.
1982: Ulrich Feige; B Overwien; C Sorg
Purification of human blood monocytes by hypotonic density gradient centrifugation in Percoll.
Journal of immunological methods 1982;54(3):309-15.
1982: C Sorg; C Ramb; B Overwien; Ulrich Feige
Use of a multiwell assembly for chemotaxis and evaluation by enzyme-linked immunosorbent assay (ELISA).
Immunobiology 1982;162(2):192-8.
1981: Ulrich Feige; Joanna Radziejewska-Lebrecht
Phosphate localization in carbohydrates - a study on enterobacterial lipopolysaccharides.
Zentralblatt für Bakteriologie. 1. Abt. Originale. A: Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie 1981;249(3):382-91.
1981: Joanna Radziejewska-Lebrecht; Ulrich Feige; H Mayer; J Weckesser
Structure of the heptose region of lipopolysaccharies from Rhodospirillum tenue.
Journal of bacteriology 1981;145(1):138-44.
1980: Joanna Radziejewska-Lebrecht; Ulrich Feige; M Jensen; K Kotełko; H Friebolin; H Mayer
Structural studies on the glucose-heptose region of the Proteus mirabilis R core.
European journal of biochemistry / FEBS 1980;107(1):31-8.